Vor Bio announced on August 18, 2025, that its Compensation Committee granted inducement awards to seven newly hired employees between August 4, 2025, and August 18, 2025. These awards included stock options to purchase an aggregate of 6,959,013 shares and restricted stock units (RSUs) representing 1,491,217 shares of common stock.
The stock options have a ten-year term with exercise prices ranging from $2.11 to $2.04 per share, equal to the closing price on their respective grant dates. These options will vest over a four-year period, with 25% vesting after 12 months and the remainder monthly over the following 36 months.
The RSUs will also vest over a four-year period, with 25% vesting after 12 months and the remaining shares vesting quarterly over the subsequent 36 months. These grants are a strategic tool to attract and retain key talent as Vor Bio builds out its team following its recent strategic pivot into autoimmune diseases.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.